Biohaven eyes mid-2021 for migraine prevention drug launch

by Raphael Stevens 19 November 2020, 00:19 189 Views

“I hope that in six months or so from now that we will be the first oral CGRP with the indication for the prevention of migraine,” Biohaven CEO Vlad Coric said.

Source: Business - cnbc.com

Trump Fed nominee Shelton faces more difficult road to confirmation

‘Thanksgiving could be a massive superspreader event,' Rhode Island emergency room doctor says

This portal is not a newspaper as it is updated without periodicity. It cannot be considered an editorial product pursuant to law n. 62 of 7.03.2001. The author of the portal is not responsible for the content of comments to posts, the content of the linked sites. Some texts or images included in this portal are taken from the internet and, therefore, considered to be in the public domain; if their publication is violated, the copyright will be promptly communicated via e-mail. They will be immediately removed.

Biohaven eyes mid-2021 for migraine prevention drug launch

Trump Fed nominee Shelton faces more difficult road to confirmation

‘Thanksgiving could be a massive superspreader event,' Rhode Island emergency room doctor says

ITALIAN LANGUAGE

ENGLISH LANGUAGE